News
NEWS

  • news

Selected to participate in JETRO's Acceleration program "SCAP"

Celaid Therapeutics has been selected by JETRO to participate in the Startup City Acceleration Program (SCAP), a support program for Japanese startups expanding overseas.

In this program, world-class accelerators affiliated with JETRO will provide specialized courses by leveraging their strengths and provide individual support for Japanese startups to expand business overseas while closely working with them.

JETRO Press Release; Acceleration program “SCAP” starts from mid-September in series to intensively assist startups in expanding business overseas

Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2022 All Rights Reserved Powered by STINGER.